120 related articles for article (PubMed ID: 29285220)
1. Dietary polyphenols influence antimetabolite agents: methotrexate, 6-mercaptopurine and 5-fluorouracil in leukemia cell lines.
Mahbub A; Le Maitre C; Haywood-Small S; Cross N; Jordan-Mahy N
Oncotarget; 2017 Dec; 8(62):104877-104893. PubMed ID: 29285220
[TBL] [Abstract][Full Text] [Related]
2. Polyphenols enhance the activity of alkylating agents in leukaemia cell lines.
Mahbub AA; Maitre CLL; Haywood-Small S; Cross NA; Jordan-Mahy N
Oncotarget; 2019 Jul; 10(44):4570-4586. PubMed ID: 31360305
[TBL] [Abstract][Full Text] [Related]
3. Polyphenols act synergistically with doxorubicin and etoposide in leukaemia cell lines.
Mahbub AA; Le Maitre CL; Haywood-Small SL; Cross NA; Jordan-Mahy N
Cell Death Discov; 2015; 1():15043. PubMed ID: 27551472
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of polyphenols on proliferation and apoptosis in human myeloid and lymphoid leukemia cell lines.
Mahbub AA; Le Maitre CL; Haywood-Small SL; McDougall GJ; Cross NA; Jordan-Mahy N
Anticancer Agents Med Chem; 2013 Dec; 13(10):1601-13. PubMed ID: 23796248
[TBL] [Abstract][Full Text] [Related]
5. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells.
Mertens-Talcott SU; Percival SS
Cancer Lett; 2005 Feb; 218(2):141-51. PubMed ID: 15670891
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.
Keane MM; Ettenberg SA; Nau MM; Russell EK; Lipkowitz S
Cancer Res; 1999 Feb; 59(3):734-41. PubMed ID: 9973225
[TBL] [Abstract][Full Text] [Related]
7. Individual and interactive effects of apigenin analogs on G2/M cell-cycle arrest in human colon carcinoma cell lines.
Wang W; VanAlstyne PC; Irons KA; Chen S; Stewart JW; Birt DF
Nutr Cancer; 2004; 48(1):106-14. PubMed ID: 15203384
[TBL] [Abstract][Full Text] [Related]
8. Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up-front treatment of acute lymphoblastic leukemia.
Dervieux T; Hancock ML; Pui CH; Rivera GK; Sandlund JT; Ribeiro RC; Boyett J; Evans WE; Relling MV
Clin Pharmacol Ther; 2003 Jun; 73(6):506-16. PubMed ID: 12811360
[TBL] [Abstract][Full Text] [Related]
9. III. IMPROVEMENT OF CANCER CHEMOTHERAPY IN MAN.
BURCHENAL JH
Acta Unio Int Contra Cancrum; 1964; 20():48-51. PubMed ID: 14151968
[No Abstract] [Full Text] [Related]
10. A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation.
Xiao Z; Xue J; Sowin TJ; Rosenberg SH; Zhang H
Oncogene; 2005 Feb; 24(8):1403-11. PubMed ID: 15608676
[TBL] [Abstract][Full Text] [Related]
11. p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines.
Petak I; Tillman DM; Houghton JA
Clin Cancer Res; 2000 Nov; 6(11):4432-41. PubMed ID: 11106264
[TBL] [Abstract][Full Text] [Related]
12. Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines.
Scott J; Dorr RT; Samulitis B; Landowski TH
Cancer Chemother Pharmacol; 2007 May; 59(6):749-57. PubMed ID: 17333195
[TBL] [Abstract][Full Text] [Related]
13. Effect of antimetabolites on epidermal structures.
NURSE DS
Arch Dermatol; 1963 Feb; 87():258-65. PubMed ID: 13939252
[No Abstract] [Full Text] [Related]
14. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
Kim K; Blechman WJ; Riddle VG; Pardee AB
Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
[TBL] [Abstract][Full Text] [Related]
15. Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines.
Ramilo-Torno LV; Avramis VI
Cancer Chemother Pharmacol; 1995; 35(3):191-9. PubMed ID: 7805176
[TBL] [Abstract][Full Text] [Related]
16. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.
Dubrez L; Goldwasser F; Genne P; Pommier Y; Solary E
Leukemia; 1995 Jun; 9(6):1013-24. PubMed ID: 7596166
[TBL] [Abstract][Full Text] [Related]
17. Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity.
Nygaard U; Toft N; Schmiegelow K
Clin Pharmacol Ther; 2004 Apr; 75(4):274-81. PubMed ID: 15060506
[TBL] [Abstract][Full Text] [Related]
18. Divergent cytotoxic effects of PKC412 in combination with conventional antileukemic agents in FLT3 mutation-positive versus -negative leukemia cell lines.
Furukawa Y; Vu HA; Akutsu M; Odgerel T; Izumi T; Tsunoda S; Matsuo Y; Kirito K; Sato Y; Mano H; Kano Y
Leukemia; 2007 May; 21(5):1005-14. PubMed ID: 17330105
[TBL] [Abstract][Full Text] [Related]
19. Comparative sensitivity to various antimetabolites of several established cell lines derived from the buffy coat of normal humans and patients with neoplastic diseases.
Aoki Y; Moore GE
Cancer Res; 1969 Jun; 29(6):1307-12. PubMed ID: 5256298
[No Abstract] [Full Text] [Related]
20. Novel analogs of 1,25-dihydroxyvitamin D
Nachliely M; Sharony E; Kutner A; Danilenko M
J Steroid Biochem Mol Biol; 2016 Nov; 164():59-65. PubMed ID: 26365556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
